INS and diabetes mellitus: However, the large difference between German and Norwegian Treatment scores from 2009 and 2017 (56.4 vs. 65.2) can support the nation that advances in diabetes treatment, such as the accessibility of insulin analogues and diabetes technology lead to better treatment related quality of life.